Literature DB >> 34714614

Trends of Colorectal Cancer Incidence in Kazakhstan.

Dana Mauyenova1,2, Yerkezhan Zhadykova1,2, Arman Khozhayev3, Dulat Turebayev1,2, Dariyana Kulmirzayeva2,4, Saltanat Urazova1,2, Gaukhar Nurtazinova1,2, Yerlan Kuandykov2,5, Akmaral Amanshayeva2, Sauirbay Sakhanov1,2, Zhanar Bukeyeva1,2, Vladimir Openko1,2, Serikbay Orazbayev1,2, Saken Kozhakhmetov1,2, Zarina Bilyalova2, Gulnur Igissinova2,3, Alireza Alireza Mosavi Jarrahi6, Nurbek Igissinov1,2,7.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 34714614      PMCID: PMC8858261          DOI: 10.31557/APJCP.2021.22.10.3405

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


× No keyword cloud information.

Introduction

Colorectal cancer (CRC) remains one of the most widespread human malignancies. According to the International Agency for Research on Cancer, about 1.93 million new cases of CRC were registered in 2020 worldwide, and the age-standardized incidence rate (ASR) of CRC is 19.5 per 100,000. About 50.3% of all new CRC cases occur in Asia and its incidence is 17.6 per 100,000 in this region (Ferlay et al., 2020A). According to Global Cancer Observation, the number of new CRC cases in the world will increase by 63% in 2040 (about 3.15M) (Ferlay et al., 2020B). There is a wide geographic variation in CRC incidence (Ferlay et al.,2020) due to dietary characteristics (Baena and Salinas, 2015; Yang and Yu, 2018), bad habits (Fliss-Isakov et al., 2018), environmental factors, and genetically driven susceptibility (Johnson et al., 2013; Gu et al.,2018; Keum and Giovannucci, 2019; Mattiuzzi et al., 2019). In the recent decades, dietary and food consumption patterns of the population have changed (Chun et al., 2010; Kearney, 2010). For instance, there have been many changes in water consumption (Muckelbauer et al., 2016), food processing and storage technologies (Orlien and Bolumar, 2019), and the use of preservatives, stabilizers, aroma enhancers, synthetic dyes, and other food additives (Eskola et al., 2020). In agriculture sector, different technologies are used to accelerate production of breeding material. In addition, hormonal drugs and antibiotics are used (Liu et al., 2017; Oliveira et al., 2020), most likely leading to a change in the normal human microbiota and malignant transformation of cells (Murphy et al., 2019). CRC develops as a result of degeneration of adenomatous polyps (Lucas et al., 2017). Two of the main risk factors associated with CRS are hereditary (Mármol et al., 2017) and familial and factors (Valle, 2017; Boland et al., 2018). Other known predisposing factors include inflammatory bowel disease (ulcerative colitis, Crohn’s disease) and the duration of the disease (Nadeem et al., 2020). The overall incidence of CRC begins to increase approximately 8-10 years after the onset of inflammatory bowel disease and increases to 15-20% after 30 years (Eaden et al., 2001). The main risk factors are the duration of the disease, the prevalence of the lesion, young age, and the presence of complications (Dyson and Rutter, 2012). Age is a significant risk factor for the development of CRC. CRC is rare until the age of 40, but the incidence of CRC increases in each subsequent decade and peaks at 60-75 years (Siegel et al., 2017). The high frequency of CRC is attributed to low fiber, high animal protein, fat, and refined carbohydrate food content (Baena and Salinas, 2015). Obesity increases the risk of CRC by about 1.5 times or more in men (Dong et al., 2017). Alcohol consumption, smoking, and inherited colon diseases also increase the sporadic incidence of colon polyposis and CRC (Amitay et al., 2020). Screening tests significantly reduce CRC incidence by detecting precancerous bowel disease or the cancer at early stage, allowing for timely medical treatment (Rex et al., 2017; Lauby-Secretan et al., 2018; Ladabaum et al., 2020). WHO recommends preventive examinations, namely doing fecal occult blood test every year from the age of 50. In case of a positive test result, a more detailed examination of the colon, such as colonoscopy, should be carried out (Winawer et al., 1995). Since 2011, screening for CRC has been carried out in Kazakhstan among the entire population aged 50 to 70 every two years using fecal occult blood test and colonoscopy procedure. This is a continuation of several studies of the dynamics in malignant neoplasms incidence by the method of component analysis, we conducted studies in this direction earlier (Igissinov et al., 2012; Igissinov et al., 2013; Igissinov et al., 2015; Kuanyshkaliyeva et al., 2016; Igissinov et al., 2019), assessing the influence of demographic factors, risk factors and their combination at the same time, taking into account gender, ethnic groups in different localities. The aim of the study was to use principal components analysis to shed light on the dynamics of the incidence of CRC in Kazakhstan.

Materials and Methods

Patient recruitment The cancer registry of the population of Kazakhstan covers 14 regions and cities of Almaty and Astana (now the city of Nur-Sultan). New cases of CRC were extracted from case report forms presented by the Ministry of Healthcare of the Republic of Kazakhstan (form 7 and form 35) from 2009 to 2018 (International Classification of Diseases – 10, , 10th Revision code C18-21). Population denominators The population of Kazakhstan was 18.2 million in 2018. Population denominators for the calculation of incidence rates from 2009 to 2018 were provided by the National Bureau of Statistics of Kazakhstan. At the same time, data on the number of populations of the republic, taking into account the studied regions, are used, all data are presented on the official website (Bureau of National Statistics, 2021). Statistical analysis Age-specific incidence rates (ASIRs) were calculated for eighteen different age groups (0-4, 5-9, …, 80-84, and 85+) using the world standard population proposed by WHO (Ahmad et al., 2001) and according to the recommendations developed by the National Cancer Institute (NCI, 2013). The extensive, crude (CR) and ASIRs were determined based on the generally accepted methodology used in sanitary statistics Accordingly, the annual averages (M, P), mean error (m), Student criterion, 95% confidence interval (95% CI), and average annual upward/downward rates (T, %) were calculated (Merkov and Polyakov, 1974; Glanz, 1998; dos Santos Silva, 1999; Tango, 2010; Merabishvili, 2015). Trends were determined using the least squares method, and the average annual growth rates were calculated using the geometric mean. The dynamics of indicators was investigated using component analysis according to methodological recommendations (Dvoyrin and Aksel, 1987; Chissov et al., 2007). The component method was used in this study to decompose the increase in the number of cases in the same population, but at different time periods. According to this method, 7 components of the increase in the number of cases were considered. The first 3 components were associated with changes in the population size, its age structure, and the combined influence of these factors. The true increase in the number of patients was due to the change only in the indicator of the risk of acquiring illness and was represented by the 4th component. The next 3 components were associated with the risk of acquiring illness, an increase in the population, a change in its age structure, and the influence of all three factors. Thus, the last 4 components were associated with an increase in the risk of developing the disease. By “risk of acquiring illness”, we meant the whole complex of reasons that could lead to an increase, decrease, or stabilization of the incidence. Reviewing and processing of the received materials was carried out using the Microsoft 365 software package (Excel, Word, PowerPoint). In addition, online statistical calculators were used (https://medstatistic.ru/calculators/averagestudent.html), where Student criterion was calculated when comparing the average values. Ethics approval Since this study involved the analysis of publicly available administrative data and did not involve contacting individuals, obtaining permission from an ethics committee was not required.

Results

During the study period, 28,950 new cases of CRC were registered in the country (13,779 (47.6%) in men and 15,171 (52.4%) in women). The highest proportion of CRC patients (both sexes) aged 60 to 69 years old (60-64 years old:15.9% and 65-69 years old: 15.5%) (Table 1).
Table 1

Number and Age-Specific Incidence rate of CRC in Kazakhstan, 2009-2018

AgeAllMaleFemale
Number (%)IncidenceNumber (%)IncidenceNumber (%)Incidence
per 100,000Т, %R2per 100,000Т, %R2per 100,000Т, %R2
<30224 (0.8)0.26±0.02−1.60.0672127 (0.9)0.29±0.02−1.60.060197 (0.6)0.23±0.03−1.50.0121
30-34269 (0.9)2.0±0.20.40.0026136 (1.0)2.1±0.21.80.0411133 (0.9)2.0±0.2−1.00.0138
35-39473 (1.6)4.0±0.22.10.2455233 (1.7)4.0±0.20.20.0009240 (1.6)3.9±0.24.00.4537
40-44819 (2.8)7.4±0.3−0.10.0008418 (3.0)7.8±0.31.60.1484401 (2.6)7.0±0.4−1.90.093
45-491381 (4.8)13.0±0.41.10.1374674 (4.9)13.3±0.61.60.1089707 (4.7)12.6±0.50.60.0222
50-542558 (8.8)25.5±0.7−0.70.05651236 (9.0)26.4±0.710.14121322 (8.7)24.7±1.1−2.20.2749
55-593891 (13.4)47.4±1.10.30.01291927 (14.0)52.3±1.81.30.12871964 (12.9)43.4±1.4−0.70.0555
60-644614 (15.9)77.0±1.60.30.01652273 (16.5)89.7±3.10.40.01652341 (15.4)67.7±1.20.10.0027
65-694488 (15.5)113.1±6.13.70.46112189 (15.9)138.1±7.84.70.66152299 (15.2)96.7±5.52.80.2401
70-744240 (14.6)128.2±2.4−0.20.00911988 (14.4)163.3±3.50.40.02872252 (14.8)107.8±2.3−0.60.0788
75-793746 (12.9)151.9±4.20.30.01071696 (12.3)205.6±6.2−0.40.02012050 (13.5)124.7±4.210.0883
80-841648 (5.7)127.5±5.72.90.4099644 (4.7)169.5±10.23.50.32621004 (6.6)110.0±5.12.20.2263
85+599 (2.1)81.1±3.70.10.0009238 (1.7)131.6±9.4−1.50.0431361 (2.4)64.8±4.50.50.0046
CR28950 (100.0)16.9±0.420.732713779 (100.0)16.7±0.52.60.735615171 (100.0)17.2±0.31.40.5218
ASR18.1±0.310.318221.9±0.51.40.406215.9±0.10.40.0724

T, average annual upward/downward rates; R2, the value of the approximation confidence; CR, crude rate; ASR, age-standardized rate

Age-related indicators of the incidence of CRC (per 100,000) peaked in the age group of 75-79 years in both sexes (151.9±4.2) ( male :205.6±6.2 , female :124.7±4.2) (Table 1). Trends of ASIR of CRC in the entire population tended to increase in almost all age groups, except for the age group of 40-44 years old (T=−0.1%), 50-54 years old (T=−0.7%), and 70-74 years old (T=−0.2%). Trends of ASIR in the male population decreased in the age group of 75-79 (T=−0.4%), and 85 , and older (T=−1.5%). In the female population, the age indicators decreased in the age group of 30-34 (T=−1.0%), 40-44 (T=−1.9%), 50-54 (T=−2.2%), 55-59 (T=−0.7%), and 70-74 (T=−0.6%). It should be noted that the value of the accuracy of the approximation of the listed decreases was not significant (Table 1). Trends of age indicators generally affected the overall incidence rates, so the crude rate of CRC incidence in the total population of the country increased from 14.79 (2009) to 17.72 in 2018 (p=0.000), the total increase was 2.93 per 100,000 (Table 2) and depended on changes (per 100,000) in the age structure of the population (∑ΔA=+1.42), the risk of acquiring illness (∑ΔR=+1.31), and the combined influence of the risk of acquiring illness and the age structure (∑ΔRA=+0.20). At the same time, the average annual growth rate of the aligned indicator was T=+2.0%, and the approximation confidence value was close to 1 (R2=0.7327).
Table 2

Component Analysis of CRC Incidence Growth in Kazakhstan, 2009-2018

Age group(i)Age structureGrowth of structural indicators(Si2−Si1)(3)−(2)Incidence, per 100,000Incidence growth, per 100,000
General(Pi2−Pi1)(6)−(5)Including due to changes of
2009(Si1)2018(Si2)20092018ΔAΔRΔRA
(P i1 ) (P i2 ) (4)×(5)(2)×(7)(4)×(7)
12345678910
Both sexes
<300.52170.5011−0,02060.290.23−0,06−0,006−0,031+0,001
30-340.07610.08370.00751.972.50.530.0150.040.004
35-390.07110.0699−0.00123.354.340.99−0.0040.07−0.001
40-440.06690.0634−0.00366.828.351.52−0.0240.102−0.005
45-490.06890.0589−0.010013.2513.08−0.17−0.133−0.0110.002
50-540.05520.05590.000822.1225.112.990.0170.1650.002
55-590.04320.05410.010946.5145.84−0.660.506−0.029−0.007
60-640.02560.03990.014375.7875.45−0.321.086−0.008−0.005
65-690.02520.02950.004379.89111.1931.30.3440.7890.135
70-740.02270.0144−0.0083127.66122.18−5.48−1.061−0.1240.046
75-790.01170.01590.0042130.22137.957.730.5420.0910.032
80-840.00820.00860.0004125.41158.0332.620.0490.2670.013
85+0.00340.00480.001372.6365.77−6.860.096−0.024−0.009
Total ∑S i1 =1.0 ∑S i2 =1.0 P 1 =14.79 P 2 =17.72 2.93 ∑Δ A =+1.42 ∑Δ R =+1.31 ∑Δ RA =+0.20
Male*
Total ∑S i1 =1.0 ∑S i2 =1.0 P 1 =14.69 P 2 =17.69 3 ∑Δ A =+1.72 ∑ΔR=+1.24 ∑Δ RA =+0.04
Female*
Total ∑S i1 =1.0 ∑S i2 =1.0 P 1 =14.89 P 2 =17.76 2.87 ∑Δ A =+1.20 ∑Δ R =+1.33 ∑Δ RA =+0.34

ΔA, the age structure of the population; ΔR, risk of acquiring illness; ΔRA, risk of acquiring illness and age structure of the population; *The calculations were made in the same way as for the entire population.

In the male population of the republic, the CRC also increased from 14.69 (2009) to 17.69 in 2018 per 100,000, indicating a statistically significant difference (p=0.000). The overall increase (+3.00 per 100,000) depended mainly on changes in the age structure of the population (∑ΔA=+1.72) and the risk of acquiring illness (∑ΔR=+1.24). However, their combined effect was not pronounced (∑ΔRA=+0.04) (Table 2). The average annual growth crude incidence rate was T=+2.6% and the approximation value was R2=0.7356 (Table 1). In the female population of the country, the overall increase (+2.87) in crude incidence rates from 14.89 (2009) to 17.76 per 100,000 (2018) (p=0.000) depended on changes in the age structure of the population (∑ΔA=+1.20), the risk of acquiring illness (∑ΔR=+1.33), and the combined effect of the risk of acquiring illness and the age structure (∑ΔRA=+0.34) (T=+1.4; R2=0.5218) (Tables 1 and 2). Furthermore, we used principal components analysis to shed light on the dynamics of the incidence of CRC in Kazakhstan (Tables 3 and 4). The results showed that the increase in the number of patients with CRC in the republic was associated with the influence of the following factors:
Table 3

Component Analysis of the Dynamics of CRC Incidence in Kazakhstan from 2009 till 2018

Age group (i)Number (nij)Population number (Nij)Crude incidence (PijC)Standardized END in 2018
2009 (j=1)2018 (j=2)2009 (j=1)2018 (j=2)2009 (j=1)2018 (j=2)2009 (j=1)2018 (j=2) (P ij N i2 10 -5 ) (6)×(5)×10-5
12345678910
Both sex
<302421833830890994740.290.230.1226.2
30-342438121665315190701.972.50.1930
35-393855113597112685643.354.340.30842.4
40-447396106972611502886.828.350.55978.5
45-491461401101902107001413.2513.080.902141.8
50-54195255881544101546922.1225.111.385224.6
55-5932145069024598158146.5145.841.98456.5
60-6431054740908472493975.7875.451.931549.4
65-6932259640303253602179.89111.192.804428.3
70-74463319362684261088127.66122.182.773333.3
75-79244398187376288503130.22137.951.617375.7
80-84164246130769155662125.41158.031.293195.2
85+4057550768666472.6365.770.22762.9
Total n 1=2364 n 2=3218 N 1=15982370 N 2=18157337 P 1=14.79 P 2=17.72 P 1 C =14.79 P 2 C =16.09 E(n 2 )=2945
Growth
Male*
Total n 1=1131 n 2=1555 N 1=7698875 N 2=8791298 P 1=14.69 P 2=17.69 P 1 C =14.69 P 2 C =15.93E(n2))=1443
Growth
Female*
Total n 1=1233 n 2=1663 N 1=8283495 N 2=9366039 P 1=14.89 P 2=17.76 P 1 C =14.89 P 2 C =16.22E(n2)=1506
Growth

END, the expected number of diseases; *, The calculations were made in the same way as for the entire population.

Table 4

Influencing Components on the Number of Cases of CRC in Kazakhstan

Components of growth in the number of cases due to:Both sexesMaleFemale
AN% growthAN% growthAN% growth
to (n2-n1)to n1to (n2-n1)to n1to(n2-n1)to n1
1. Growth PN 32237.713.616037.814.216137.513.1
2. Changes ASP 22726.69.613231.211.79923.18
3. Combined effect of changes in PN and ASP 313.61.3194.41.71331.1
∑1-3=+67.8 ∑1-3=+24.5∑1-3=+73.5 ∑1-3=+27.6∑1-3=+63.5 ∑1-3=+22.2
4. Change of RAI 21024.68.99522.58.411025.79
5. Combined effect of changes of RAI and PN 293.31.2143.21.2143.41.2
6. Combined effect of changes of RAI and ASP 323.71.330.70.3286.62.3
7. Combined effect of the changes RAI, PN and ASP 40.50.200.10.0440.90.3
∑1-3=+32.2 ∑1-3=+11.6∑1-3=+26.5 ∑1-3=+9.9∑1-3=+36.5 ∑1-3=+12.7
Total ∑1-785410036.142410037.543010034.9

AN, absolute number; PN, population number; ASP, age structure of the population; RAI, risk of acquiring illness

1. Growth of population number ΔP=+37.7% (male – ΔP=+37.8%; female – ΔP=+37.5%). 2. Changes in the age structure of the population ΔA=+26.6% (male – ΔA=+31.2%; female – ΔA=+23.1%). 3. Combined effect of changes in population number and its age structure ΔPA=+3.6% (male – ΔPA=+4.4%; female – ΔPA=+3.0%). 4. Change in the risk of acquiring illness ΔR=+24.6% (male – ΔR=+22.5%; female – ΔR=+25.7%). 5. Combined effect of changes in the risk of acquiring illness and population number ΔRP=+3.3% (male – ΔRP=+3.2%; female – ΔRP=+3.4%). 6. Combined effect of changes in the risk of acquiring illness and age structure of the population ΔRA=+3.7% (male – ΔRA=+0.7%; female – ΔRA=+6.6%). 7. Combined effect of the changes in the risk of acquiring illness, population number, and its age structure ΔRAP=+0.5% (male – ΔRAP=+0.1%; female – ΔRAP=+0.9%). The total increase in the absolute number of new cases of CRC (both sex) was equal to the sum of the components: n2−n1=322+227+31+210+29+32+4=854 or +36.1% (Table 4) in comparison with the primary number of patients (854÷2364×100=36.1%). Accordingly, the components of the increase as a percentage of the initial level was equal to: Thus, CRC (both sexes) was characterized by an increase in the number of cases because of the changes in the total population size and its structure (24.5% of the total increase of 36.1%). The real increase in the number of cases (risk of acquiring illness) was ΔR=+8.9%. The increase in new cases of CRC in men and women is presented in Table 4, indicating no significant difference with respect to sex. It should be noted that during the study period, the number of patients (both sexes) in the country increased by 36.1% (from 2,364 to 3,218), which was higher than the estimation obtained by the component analysis (– 2,945) (Table 3). The increase was due to demographic factors (ΔP+A+PA=+67.8%) and the combined influence of risk factors for acquiring illness with demographic components (ΔR+RP+RA+RAP=+32.2%). In men, the influence of demographic factors was slightly more pronounced (ΔP+A+PA=+73.5%), while the combined influence of risk factors and demographic factors was less pronounced (ΔR+RP+RA+RAP=+26.5%). Among women, the impact of demographic indicators led to an increase in patients (ΔP+A+PA=+63.5%), and the combined influence of risk factors and changes in demographic indicators also played a role (ΔR+RP+RA+RAP=+36.5%). The dynamics of the incidence of CRC had regional characteristics. So that, in the Kostanay region, there was an overall increase (+9.42) in the incidence of CRC (per 100,000) in the entire population, from 23.02 in 2009 to 32.43 in 2018 (p=0.000) (Table 5), which primarily depended on the risk of acquiring illness (∑ΔR=+5.63 per 100,000) and secondly on changes in the age structure of the population (∑ΔA=+3.89 per 100,000). In contrast, the combined effect of the age structure and the risk of acquiring illness reduced this indicator (∑ΔRA=−0.11 per 100,000). At the same time, the average annual growth rate of the aligned indicator was Т=+3.0%, and the confidence value of the approximation was equaled to R2=0.5708. Having studies the role of various components, it was found (Table 5) that the incidence of new cases in this region was associated with demographic factors (ΔP+A+PA=+39.5%) and the complex influence of the risk of acquiring illness (ΔR=+62.4%) with the components of the population size, its age structure, and the influence of all the three above-mentioned factors (ΔR+RP+RA+RAP=+60.5%).
Table 5

Component Analysis of CRC Incidence Growth with Respect to Regions of Kazakhstan, 2009-2018

RegionsIncidence,Incidence growth, per 100,000T, %pR2ANChange/Combined, %Total
per 100,000general*IncludingΔPΔAΔPAΔRΔRPΔRAΔRAP
20092018ΔAΔRΔRA
Almaty city21.9522.030.080.81−0.990.25−1.610.34759898.611.33.6−13.8−4.43.51.1100
North Kazakhstan28.1228.460.355.62−2.72−2.550.50.90.0649−9−121.7373−24.3−180.411.8−169.411100
Pavlodar29.3730.20.843.79−3.700.742.50.7770.42361036.9281.64.8−274.6−4.755.10.9100
Mangystau6.847.881.041.1−0.100.042.20.5010.17591963.927.910.3−2.5−0.910.4100
Zhambyl6.868.231.380.720.310.351.60.2820.16562230.133.53.214.21.316.21.5100
South Kazakhstan5.286.91.620.870.86−0.124.20.0240.56747234.229.85.629.55.6−4.0−0.8100
Kyzylorda6.348.041.71.720.68−0.701.40.2320.09992033.458.29.123.23.6−23.9−3.7100
Astana city18.0119.991.982.27−0.01−0.2810.3640.0384977914.29.9±0.0±0.0−1.8−1.2100
West Kazakhstan17.8820.712.832.060.97−0.202.10.2590.40352732.245.73.721.51.7−4.5−0.4100
Kazakhstan14.7917.722.931.421.310.2200.732785437.726.63.624.63.33.70.5100
Almaty 7.76113.240.62.430.213.50.0010.28238220.213.21.653.56.34.60.5100
Atyrau 8.8414.345.50.214.60.695.40.0060.62444422.42.40.553.211.781.8100
Akmola18.5424.495.951.931.332.694.70.0130.76344±0.032.5±0.022.3±0.045.1±0.0100
East Kazakhstan22.5528.766.213.093.070.042.70.0010.650283-3.652.1−0.551.7−0.50.8±0.0100
Karaganda20.0626.446.382.153.620.612.80.0070.5941968.2300.950.61.58.50.2100
Aktobe 10.1717.026.851.834.230.794.100.60066914.9202.746.46.28.71.2100
Kostanay23.0232.439.423.895.63−0.11300.570880-3.143.1−0.562.4−0.8−1.2±0.0100

*The table is built taking into account the sorting from A to Z of the general growth; T, average annual upward/downward rates; p, significance level; R2, the value of the approximation confidence; AN, absolute number; ΔP, population number; ΔA, the age structure of the population; ΔPA, population number and its age structure; ΔR, risk of acquiring illness; ΔRP, risk of acquiring illness and population number; ΔRA, risk of acquiring illness and age structure of the population; ΔRAP, risk of acquiring illness, population number and its age structure.

Following the analysis of the average annual growth rate of aligned indicators of CRC incidence in the entire population, it was detected that the most pronounced growth was in the Akmola (Т=+4.7%; R2=0.7630) and Atyrau regions (Т=+5.4%; R2=0.6244). This growth was statistically significant in 2018 in comparison with 2009, and the values of the accuracy of the approximation were pronounced (Table 5). Regarding the influence of various components with respect to region for the entire population (Table 5), it was found that there was a pronounced decrease in the North Kazakhstan region (ΔP=−121.7%) due to changes in the population size, and the largest increase was allocated to Almaty city (ΔP=+98.6%). The role of the influence of age structure in the increase in the number of patients was positive in all regions, but it was mostly pronounced in the Pavlodar (ΔA=+281.6%) and North Kazakhstan (ΔA=+373.0%) regions. The combined effect of changes in the population size and its age structure showed a decline only in the North Kazakhstan region (ΔPA=−24.3%), while there was an increase in other regions, especially in Kyzylorda (ΔPA=+9.1%) and Mangystau (ΔPA=+10.3%) regions, as well as in Astana city (ΔPA=+9.9%). The decrease in the absolute number of patients with CRC due to the risk of acquiring illness was most pronounced in North Kazakhstan (ΔR=−180.4%) and Pavlodar (ΔR=−274.6%) regions, and the maximum increase was found in Atyrau (ΔR=+53.2%), Almaty (ΔR=+53.5%), and Kostanay (ΔR=+62.4%) regions. A pronounced increase in the combined impact of the risk of acquiring illness and the population size was found in Atyrau (ΔRP=+11.7%) and North Kazakhstan (ΔRP=+11.8%) regions. Changes in the risk of acquiring illness and the age structure led to a sharp decrease in the number of patients in the North Kazakhstan region (ΔRA=−169.4%), and the maximum rise was noted in Pavlodar region (ΔRA=+55.1%). In the North Kazakhstan region, the increase in the number of patients was highest compared to other regions due to the combined influence of the risk of acquiring illness, population size, and age structure (ΔRAP=+11.0%) . In a nutshell, the component analysis revealed geographical variability in the dynamics of the number of patients and the incidence of CRC in Kazakhstan, which was associated with a difference in the influence of demographic factors (changes in population size, its age structure) and the risk of acquiring illness (i.e., a set of reasons that led to an increase, decrease, or stabilization of the rates). Number and Age-Specific Incidence rate of CRC in Kazakhstan, 2009-2018 T, average annual upward/downward rates; R2, the value of the approximation confidence; CR, crude rate; ASR, age-standardized rate Component Analysis of CRC Incidence Growth in Kazakhstan, 2009-2018 ΔA, the age structure of the population; ΔR, risk of acquiring illness; ΔRA, risk of acquiring illness and age structure of the population; *The calculations were made in the same way as for the entire population. Component Analysis of the Dynamics of CRC Incidence in Kazakhstan from 2009 till 2018 END, the expected number of diseases; *, The calculations were made in the same way as for the entire population. Influencing Components on the Number of Cases of CRC in Kazakhstan AN, absolute number; PN, population number; ASP, age structure of the population; RAI, risk of acquiring illness Component Analysis of CRC Incidence Growth with Respect to Regions of Kazakhstan, 2009-2018 *The table is built taking into account the sorting from A to Z of the general growth; T, average annual upward/downward rates; p, significance level; R2, the value of the approximation confidence; AN, absolute number; ΔP, population number; ΔA, the age structure of the population; ΔPA, population number and its age structure; ΔR, risk of acquiring illness; ΔRP, risk of acquiring illness and population number; ΔRA, risk of acquiring illness and age structure of the population; ΔRAP, risk of acquiring illness, population number and its age structure.

Discussion

The results of this study showed that the incidence rate of CRC was as high as 16.9 cases per 100,000 in Kazakhstan, while the difference between men (16.7) and women (17.2) was not statistically significant in this regard. However, it was found that the ASRs was significantly higher in men (21.9) than women (15.9). Generally, the ASRs of the CRC was 18.1 cases per 100,00, revealing that Kazakhstan is moving into a zone of high incidence (Ferlay et al., 2020a). In terms of gender, the lowest rates in men was reported (per 100,000) in Mozambique (3.6) and Burkina Faso (3.6), and in women were reported in Bhutan (1.9) and Tajikistan (2.9). The highest rates of CRC in men were found in Slovakia (60.7) and Hungary (62.0), and in women were found in Denmark (35.6) and Norway (38.7) (Ferlay et al., 2020a). The results on age-related incidence indicators in the country had high values in patients over 65 years of age. Similar results were found in French Polynesia (111.2 per 100,000), Jordan (114.8), Georgia (120.2), and United Arab Emirates (122.5). This pattern was repeated in men population and there were alike indicators in Saint Lucia (140.7), Qatar (141.2), Paraguay (147.9), and Costa Rica (147.5). Whereas in women, we saw changes similar to French Polynesia (96.4), Georgia (99.6), Venezuela (100.5), and Bahrain (101.2) (Ferlay et al., 2020A). The results of the epidemiological study regarding CRC in Kazakhstan for 2004-2014 (Abdullayev et al., 2017) showed an increase in its incidence with stable trends, which was in line with our study. At the same time, there was an increase in the number of patients at stages I and II, which could be due to the influence of screening. The incidence of CRC in Kazakhstan had increasing trend, which could be due to the impact of ongoing anti-cancer measures, including screening. Thus, according to Zhylkaidarova (2021), changes in morbidity can be estimated through the assessment of the impact of screening. Herewith, the regions that got a score of 0-2 points, according to our data, had a low degree of approximation reliability (i.e., changes in the trends were not significant). Our study revealed following results: Almaty city (0 points; R2=0.3475), North Kazakhstan (0 points; R2=0.0649), West Kazakhstan (1 point; R2=0.4035), Pavlodar (1 point; R2=0.4236), Kyzylorda (2 points; R2=0.0999), and Mangistau (2 points; R2=0.1759). Akmola (3 points; R2=0.7630), Kazakhstan (3 points; R2=0.7327), Aktobe (4 points; R2=0.6006), Karaganda (4 points; R2=0.5941), Kostanay (4 points; R2=0.5708), and South Kazakhstan (4 points; R2=0.5674) had a significant degree of approximation. In Atyrau (R2=0.6244) and East Kazakhstan (R2=0.6502), the degrees of approximation were significant. In Almaty (R2=0.2823), Zhambyl region (R2=0.1656), and Astana city (R2=0.0384), the degrees of accuracy of the approximation were not very pronounced, especially in the capital. These findings could be due to this fact that the authors did not study the growth rates of the dynamic series but compared the initial and final data of the studied period. Having investigated the effectiveness of screening programs in the Almaty region for 2018-2020 (Zholmurzayeva et al., 2021), it was revealed that t the average response rate was 50% for the first step of screening and very low for the second step. At the same time, it should be noted that according to the data of medical and preventive institutions of the Almaty region, there was no excess load of the available endoscopic equipment. Consequently, the reasons for the insufficient response and screening were not related to the material problems of the healthcare system but to low social mobilization, which was similar to the findings of a study by Heisser (2021). The results of our studies showed a unimodal increase in age indicators, which peaked at the age group of 75-79 years, and its incidence in this age group of men was almost twice as high. CRC incidence in the world in the age groups of 70 years and older was highest in Denmark (389.8 per 100,000 – both gender; 476.7 – male; 319.7 – female), Netherlands (390.9; 492.0; 306.1), and Norway (421.3; 473.3; 376.7) (Ferlay et al., 2020A). With respect to gender-related differences, according to randomized study (Bull et al., 2020), higher BMI increases the risk of CRC among men, while higher waist-to-hip ratio considerably raises CRC risk among women. White et al., (2018) revealed that men were more prone to get CRC than women, though they see no gender differences in diagnosis for advanced stages of disease. Alongside this, the male population is more susceptible to a number of modifiable risk factors, such as smoking and alcohol intake (Rawla et al., 2019). Declining trends of age indicators in women aged under 30, 30-34, 40-44, 50-59, 70-74 years old were notable. In other words, there was no increase in the diagnosis of this disease especially in screening target group (50-75 years). This phenomenon may be due to insufficient social mobilization, which needs health managers’ more attention. Meanwhile, a previous study revealed an association between reduction of morbidity and mortality and performing colonoscopy (Brown et al., 2021). They found that during the screening measures, there was a temporary increase (between 2002-2007) in CRC incidence, but in general (between 2000-2016), morbidity and mortality rates were declined. Authors consider such changes as expected ones because of detection of patients at early stage of CRC. These findings can be attributed to the timely diagnosis and treatment of precancerous diseases. As in a previous study, a decrease in the incidence of CRC in the group subject to screening (50-74 year) was reported. The authors of aforementioned study attributed this phenomenon to the important role of screening in removal of adenomas and its notable effect on CRC incidence (Clark et al., 2020). The formation and impact of the studied factors in regions were dissimilar. The analysis of data on the CRC incidence with respect to region showed that there were certain regions where the component of “risk of acquiring illness” had no effect. However, we found the presence of certain problems in the organization of anti-cancer measures, including screening. In general, an increase in the incidence of CRC was noted in many regions, where this growth was due to the greater influence of the “risk of acquiring illness” component. It influenced the formation of the general trend in the country as a whole resulting from anti-cancer measures in CRC, including screening. Unfortunately, it was not possible to compare our component analysis results with the literature data due to the lack of research in this direction. The results of component analysis indicated of the efficacy of anti-cancer measures, including CRC screening, in the country, while the influence of other exogenous and endogenous factors were not excluded.

Author Contribution Statement

DM, AA, SS, YK, GN – Collection and preparation of data, primary processing of the material and their verification. DM, SU, YZ, VO, NI – Statistical processing and analysis of the material, writing the text of the article (material and methods, results). DM, SK, DT, ZB, GI, ZhB, SO – Writing the text of the article (introduction, discussion). NI, AMJ, DM – Concept, design and control of the research, approval of the final version of the article. All authors approved the final version of the manuscript.
  40 in total

1.  The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence.

Authors:  Rachel R Huxley; Alireza Ansary-Moghaddam; Peter Clifton; Sebastien Czernichow; Christine L Parr; Mark Woodward
Journal:  Int J Cancer       Date:  2009-07-01       Impact factor: 7.396

2.  Attributable causes of colorectal cancer in China.

Authors:  Meng-Jia Gu; Qiu-Chi Huang; Cheng-Zhen Bao; Ying-Jun Li; Xiao-Qin Li; Ding Ye; Zhen-Hua Ye; Kun Chen; Jian-Bing Wang
Journal:  BMC Cancer       Date:  2018-01-05       Impact factor: 4.430

Review 3.  Microbiota, Inflammation and Colorectal Cancer.

Authors:  Cécily Lucas; Nicolas Barnich; Hang Thi Thu Nguyen
Journal:  Int J Mol Sci       Date:  2017-06-20       Impact factor: 5.923

4.  A review of sex-related differences in colorectal cancer incidence, screening uptake, routes to diagnosis, cancer stage and survival in the UK.

Authors:  Alan White; Lucy Ironmonger; Robert J C Steele; Nick Ormiston-Smith; Carina Crawford; Amanda Seims
Journal:  BMC Cancer       Date:  2018-09-20       Impact factor: 4.430

5.  Heterogeneity of Colorectal Cancer Risk Factors by Anatomical Subsite in 10 European Countries: A Multinational Cohort Study.

Authors:  Neil Murphy; Heather A Ward; Mazda Jenab; Joseph A Rothwell; Marie-Christine Boutron-Ruault; Franck Carbonnel; Marina Kvaskoff; Rudolf Kaaks; Tilman Kühn; Heiner Boeing; Krasimira Aleksandrova; Elisabete Weiderpass; Guri Skeie; Kristin Benjaminsen Borch; Anne Tjønneland; Cecilie Kyrø; Kim Overvad; Christina C Dahm; Paula Jakszyn; Maria-Jose Sánchez; Leire Gil; José M Huerta; Aurelio Barricarte; J Ramón Quirós; Kay-Tee Khaw; Nick Wareham; Kathryn E Bradbury; Antonia Trichopoulou; Carlo La Vecchia; Anna Karakatsani; Domenico Palli; Sara Grioni; Rosario Tumino; Francesca Fasanelli; Salvatore Panico; Bas Bueno-de-Mesquita; Petra H Peeters; Björn Gylling; Robin Myte; Karin Jirström; Jonna Berntsson; Xiaonan Xue; Elio Riboli; Amanda J Cross; Marc J Gunter
Journal:  Clin Gastroenterol Hepatol       Date:  2018-07-26       Impact factor: 11.382

6.  Biochemical and Nutritional Changes during Food Processing and Storage.

Authors:  Vibeke Orlien; Tomas Bolumar
Journal:  Foods       Date:  2019-10-14

7.  Thyroid Cancer in Kazakhstan: Component Analysis of Incidence Dynamics.

Authors:  Nurbek Igissinov; Saken Kozhakhmetov; Marzhan Zhantubetova; Gulnur Igissinova; Zarina Bilyalova; Gulnur Akpolatova; Vladimir Lyust; Sarsembi Koblandin; Dulat Turebayev; Kairat Adaibayev; Ardak Omarbekov; Dinara Tarzhanova; Akmaral Zhantureyeva; Askar Esseyev
Journal:  Asian Pac J Cancer Prev       Date:  2019-09-01

8.  The IARC Perspective on Colorectal Cancer Screening.

Authors:  Béatrice Lauby-Secretan; Nadia Vilahur; Franca Bianchini; Neela Guha; Kurt Straif
Journal:  N Engl J Med       Date:  2018-03-26       Impact factor: 176.079

9.  Variation in changes in the incidence of colorectal cancer by age and association with screening uptake: an observational study.

Authors:  Gavin Rc Clark; Annie S Anderson; Thomas G Godfrey; Judith A Strachan; Callum G Fraser; Robert Jc Steele
Journal:  BMJ Open       Date:  2020-09-22       Impact factor: 2.692

10.  Adiposity, metabolites, and colorectal cancer risk: Mendelian randomization study.

Authors:  Caroline J Bull; Joshua A Bell; Neil Murphy; Eleanor Sanderson; George Davey Smith; Nicholas J Timpson; Barbara L Banbury; Demetrius Albanes; Sonja I Berndt; Stéphane Bézieau; D Timothy Bishop; Hermann Brenner; Daniel D Buchanan; Andrea Burnett-Hartman; Graham Casey; Sergi Castellví-Bel; Andrew T Chan; Jenny Chang-Claude; Amanda J Cross; Albert de la Chapelle; Jane C Figueiredo; Steven J Gallinger; Susan M Gapstur; Graham G Giles; Stephen B Gruber; Andrea Gsur; Jochen Hampe; Heather Hampel; Tabitha A Harrison; Michael Hoffmeister; Li Hsu; Wen-Yi Huang; Jeroen R Huyghe; Mark A Jenkins; Corinne E Joshu; Temitope O Keku; Tilman Kühn; Sun-Seog Kweon; Loic Le Marchand; Christopher I Li; Li Li; Annika Lindblom; Vicente Martín; Anne M May; Roger L Milne; Victor Moreno; Polly A Newcomb; Kenneth Offit; Shuji Ogino; Amanda I Phipps; Elizabeth A Platz; John D Potter; Conghui Qu; J Ramón Quirós; Gad Rennert; Elio Riboli; Lori C Sakoda; Clemens Schafmayer; Robert E Schoen; Martha L Slattery; Catherine M Tangen; Kostas K Tsilidis; Cornelia M Ulrich; Fränzel J B van Duijnhoven; Bethany van Guelpen; Kala Visvanathan; Pavel Vodicka; Ludmila Vodickova; Hansong Wang; Emily White; Alicja Wolk; Michael O Woods; Anna H Wu; Peter T Campbell; Wei Zheng; Ulrike Peters; Emma E Vincent; Marc J Gunter
Journal:  BMC Med       Date:  2020-12-17       Impact factor: 11.150

View more
  1 in total

1.  Colorectal Cancer Mortality in Kazakhstan: Spatio-Temporal Epidemiological Assessment.

Authors:  Dana Mauyenova; Askhat Axarin; Zhansaya Telmanova; Aida Baibusunova; Zarina Bilyalova; Gulnur Igissinova; Zhanar Bukeyeva; Akmaral Zhantureyeva; Zhanar Kozhakhmetova; Yerlan Kuandykov; Gaukhar Nurtazinova; Serikbay Orazbayev; Saken Kozhakhmetov; Indira Kudaibergenova; Alireza Mosavi Jarrahi; Nurbek Igissinov
Journal:  Asian Pac J Cancer Prev       Date:  2022-03-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.